A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

The SARS-CoV-2 pandemic caused a massive health and societal crisis, although the fast development of effective vaccines reduced some of the impact. To prepare for future respiratory virus pandemics, a pan-viral prophylaxis could be used to control the initial virus outbreak in the period prior to v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Julie, Schmidt, Signe Tandrup, Trebbien, Ramona, Cox, Rebecca Jane, Zhou, Fan, Follmann, Frank, Pedersen, Gabriel Kristian, Christensen, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836410/
https://www.ncbi.nlm.nih.gov/pubmed/35163772
http://dx.doi.org/10.3390/ijms23031850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836410/
https://www.ncbi.nlm.nih.gov/pubmed/35163772
http://dx.doi.org/10.3390/ijms23031850

Ejemplares similares